Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Iatrogenic Hypertriglyceridemia when Treating Pityriasis Rubra Pilaris: An algorithm for Monitoring and Treatment during Retinoid Therapy.

Skinmed·2024
Same author

Whole-Transcriptome Sequencing-Based Profiling of the Cutaneous Virome in Patients with Secondary Immunodeficiency.

JID innovations : skin science from molecules to population health·2024
Same author

DNA repair-related heritable photosensitivity syndromes: Mutation landscape in a multiethnic cohort of 17 multigenerational families with high degree of consanguinity.

DNA repair·2024
Same author

Weighing the Evidence for the Roles of Plasma Versus Local Pyrophosphate in Ectopic Calcification Disorders.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2023
Same author

Whole transcriptome-based skin virome profiling in typical epidermodysplasia verruciformis reveals α-, β-, and γ-HPV infections.

JCI insight·2023
Same author

Combination cryotherapy and intralesional corticosteroid versus steroid monotherapy in the treatment of keloids.

Journal of cosmetic dermatology·2022

Related Experiment Video

Updated: May 31, 2026

Reconstruct Human Retinoblastoma In Vitro
06:52

Reconstruct Human Retinoblastoma In Vitro

Published on: October 11, 2022

Cell-based therapy for RDEB: how does it work?

Jouni Uitto1

  • 1Department of Dermatology and Cutaneous Biology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA. jouni.uitto@jefferson.edu

The Journal of Investigative Dermatology
|July 15, 2011
PubMed
Summary
This summary is machine-generated.

Fibroblast therapy shows promise for recessive dystrophic epidermolysis bullosa (RDEB). Injections may stimulate the patient's own COL7A1 gene, potentially improving skin integrity in this severe blistering disorder.

More Related Videos

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

Development of a Refined Protocol for Trans-scleral Subretinal Transplantation of Human Retinal Pigment Epithelial Cells into Rat Eyes
12:45

Development of a Refined Protocol for Trans-scleral Subretinal Transplantation of Human Retinal Pigment Epithelial Cells into Rat Eyes

Published on: August 12, 2017

Related Experiment Videos

Last Updated: May 31, 2026

Reconstruct Human Retinoblastoma In Vitro
06:52

Reconstruct Human Retinoblastoma In Vitro

Published on: October 11, 2022

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

Development of a Refined Protocol for Trans-scleral Subretinal Transplantation of Human Retinal Pigment Epithelial Cells into Rat Eyes
12:45

Development of a Refined Protocol for Trans-scleral Subretinal Transplantation of Human Retinal Pigment Epithelial Cells into Rat Eyes

Published on: August 12, 2017

Area of Science:

  • Dermatology
  • Genetics
  • Regenerative Medicine

Background:

  • Recessive dystrophic epidermolysis bullosa (RDEB) is a severe genetic blistering disorder with no effective treatments.
  • Mutations in the type VII collagen gene (COL7A1) cause RDEB, leading to defective skin adhesion.
  • Allogeneic fibroblast delivery is being explored as a potential therapeutic strategy.

Discussion:

  • This study investigates the mechanism of fibroblast therapy in an RDEB patient with reduced type VII collagen.
  • Allogeneic fibroblast injection induced cytokine expression, including heparin-binding EGF-like growth factor (HB-EGF).
  • These cytokines upregulated the patient's specific COL7A1 allele, suggesting a way to restore collagen production.

Key Insights:

  • Fibroblast therapy can stimulate endogenous COL7A1 expression in RDEB.
  • Heparin-binding EGF-like growth factor (HB-EGF) plays a role in this upregulation.
  • This approach may offer a novel treatment for a subset of RDEB patients.

Outlook:

  • Fibroblast therapy presents a potential new avenue for RDEB treatment.
  • Further research is needed to optimize this therapy for specific patient subgroups.
  • This mechanism could lead to improved skin integrity and quality of life for RDEB patients.